New agents labelled with technetium 99m for myocardial perfusion imaging.
New agents labelled with technetium 99m (99mTc) are now available for myocardial perfusion imaging. In this article the author reviews the biologic characteristics, the imaging protocols and the clinical usefulness of thallous chloride Tl 201, 99mTc-sestamibi and 99mTc-teboroxime (not yet available in Canada), as well as their complementary roles in the detection of coronary artery disease.
Taillefer
R
R
Department of Nuclear Medicine, Hôtel-Dieu de Montréal, Que.
D002985:Clinical Protocols; D003327:Coronary Disease / Q000000981:diagnostic imaging*; D006801:Humans; D007267:Injections; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics; D010091:Oximes / Q000493:pharmacokinetics; D011877:Radionuclide Imaging; D013667:Technetium / Q000493:pharmacokinetics; D017256:Technetium Tc 99m Sestamibi; D013794:Thallium Radioisotopes / Q000493:pharmacokinetics
D015609:Organotechnetium Compounds; D010091:Oximes; D013794:Thallium Radioisotopes; D013667:Technetium; D017256:Technetium Tc 99m Sestamibi; C060156:technetium Tc 99m teboroxime